NCT02748330View on ClinicalTrials.gov

Platelet Inhibition of Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients After Elective Percutaneous Coronary Intervention

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions

Coronary Artery DiseaseDiabetes Mellitus, Type 2

Interventions

DRUG

Ticagrelor

DRUG

Clopidogrel

DRUG

Aspirin

Acetylsalicylic acid

Trial Locations (1)

100730

Peking Union Medical College Hospital, Beijing

All Listed Sponsors

lead

Peking Union Medical College Hospital

OTHER

NCT02748330 - Platelet Inhibition of Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients After Elective Percutaneous Coronary Intervention | Biotech Hunter | Biotech Hunter